drugset / Trial / NCT00141427

Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial.

NCT00141427

Phase 4 Completed 540 enrolled Viatris Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To assess the clinical improvement (change in seizure frequency), safety and tolerability of patients with partial seizures following adjunctive therapy of pregabalin BID in addition to existing standard AEDs.

Timeline

Start
2004-11
Primary completion
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule

Indications